| MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia CL Jones, CM Gearheart, S Fosmire, C Delgado-Martin, NA Evensen, ... Blood, The Journal of the American Society of Hematology 126 (19), 2202-2212, 2015 | 101 | 2015 |
| Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia S Dandekar, E Romanos‐Sirakis, F Pais, T Bhatla, C Jones, W Bourgeois, ... British journal of haematology 167 (1), 87-99, 2014 | 81 | 2014 |
| Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model CL Jones, T Bhatla, R Blum, J Wang, SW Paugh, X Wen, W Bourgeois, ... Journal of Biological Chemistry 289 (30), 20502-20515, 2014 | 72 | 2014 |
| Menin inhibitors in acute myeloid leukemia—what does the future hold? M Swaminathan, W Bourgeois, SA Armstrong, ES Wang The Cancer Journal 28 (1), 62-66, 2022 | 33 | 2022 |
| IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia BJ Aubrey, JA Cutler, W Bourgeois, KA Donovan, S Gu, C Hatton, ... Nature cancer 3 (5), 595-613, 2022 | 20 | 2022 |
| Asthma and subjective sleep disordered breathing in a large cohort of urban adolescents SO Zandieh, A Cespedes, A Ciarleglio, W Bourgeois, DM Rapoport, ... Journal of Asthma 54 (1), 62-68, 2017 | 20 | 2017 |
| Health care utilization and cost among pediatric patients receiving unrelated donor allogeneic hematopoietic cell transplantation W Bourgeois, A Ricci, Z Jin, M Hall, D George, M Bhatia, J Garvin, ... Bone Marrow Transplantation 54 (5), 691-699, 2019 | 11 | 2019 |
| Financial impact of post-transplant complications among children undergoing allogeneic hematopoietic cell transplantation A Ricci, Z Jin, W Bourgeois, L Broglie, M Bhatia, L Davis, D George, ... Bone Marrow Transplantation 55 (7), 1421-1429, 2020 | 6 | 2020 |
| Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML W Bourgeois, JA Cutler, BJ Aubrey, DV Wenge, F Perner, C Martucci, ... Blood 143 (15), 1513-1527, 2024 | 2 | 2024 |
| Potent Ikaros degradation by the cereblon E3 ligase modulator CC-92480 is effective in combination with Menin-MLL1 inhibition in MLL1-rearranged and NPM1-mutant AML W Bourgeois, BJ Aubrey, JA Cutler, KA Donovan, C Hatton, ACP Theall, ... Blood 138, 208, 2021 | 2 | 2021 |
| Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome BE Marks, R Sugrue, W Bourgeois, AL Frazier, SD Voss, MR Laufer, ... Journal of the Endocrine Society 5 (9), bvab098, 2021 | 2 | 2021 |
| 50 Years Ago in The Journal of Pediatrics: L-Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: Optimizing Efficacy and Minimizing Toxicity W Bourgeois The Journal of Pediatrics 224, 86, 2020 | 1 | 2020 |
| Health Care Utilization and Cost of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Malignant and Non-Malignant Diseases A Ricci, Z Jin, W Bourgeois, M Bhatia, D George, J Garvin, M Hall, ... Biology of Blood and Marrow Transplantation 24 (3), S427, 2018 | 1 | 2018 |
| Activity of the MEK inhibitor trametinib in a patient with a BRAF mutation persisting from T‐lymphoblastic lymphoma through lineage switch to CNS acute myeloid … W Bourgeois, E Yang, R Chiarle, M Burns Pediatric Blood & Cancer 71 (6), e30978, 2024 | | 2024 |
| Menin Inhibitor Induced Menin Protein Degradation Contributes to Menin Inhibitor Efficacy J Cutler, J Tsai, B Regalado, W Bourgeois, D Wenge, J Kim, R Nowak, ... Blood 142, 2788, 2023 | | 2023 |
| ANTI-FACTOR XA-BASED RISK STRATIFICATION FOR PATIENTS RECEIVING THERAPEUTIC ENOXAPARIN IS ASSOCIATED WITH INCREASED RISK OF RECURRENT/PROGRESSIVE THROMBOSIS AND HEMORRHAGE EC Drake, W Bourgeois, J Duzan, N Chen, N Ramesh, WB London, ... AMERICAN JOURNAL OF HEMATOLOGY 98, E29-E30, 2023 | | 2023 |
| Dual targeting of IKAROS and MENIN in MLL-r AML W Bourgeois, SA Armstrong, BJ Aubrey NATURE CANCER 3 (5), 532-533, 2022 | | 2022 |
